Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats
- PMID: 34452497
- PMCID: PMC8402678
- DOI: 10.3390/v13081634
Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats
Abstract
The COVID-19 pandemic raised concerns that companion animals might be infected with, and could become a reservoir of, SARS-CoV-2. As cats are popular pets and susceptible to Coronavirus, we investigated the seroprevalence of SARS-CoV-2 antibodies in shelter cats housed in Dutch animal shelters during the COVID-19 pandemic. In this large-scale cross-sectional study, serum samples of shelter cats were collected during the second wave of human COVID-19 infections in The Netherlands. Seroprevalence was determined by using an indirect protein-based ELISA validated for cats, and a Virus Neutralization Test (VNT) as confirmation. To screen for feline SARS-CoV-2 shedding, oropharyngeal and rectal swabs of cats positive for ELISA and/or VNT were analyzed using PCR tests. In 28 Dutch animal shelters, 240 shelter cats were convenience sampled. Two of these cats (0.8%; CI 95%: 0.1-3.0%) were seropositive, as evidenced by the presence of SARS-CoV-2 neutralizing antibodies. The seropositive animals tested PCR negative for SARS-CoV-2. Based on the results of this study, it is unlikely that shelter cats could be a reservoir of SARS-CoV-2 or pose a (significant) risk to public health.
Keywords: Coronavirus disease 2019 (COVID-19); animal shelter; neutralizing SARS-CoV-2 antibody; one health; serology; seroprevalence; shelter medicine; titer.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; in the decision to publish the results.
Figures
References
-
- Bosco-Lauth A.M., Hartwig A.E., Porter S.M., Gordy P.W., Nehring M., Byas A.D., VandeWoude S., Ragan I.K., Maison R.M., Bowen R.A. Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proc. Natl. Acad. Sci. USA. 2020;117:26382–26388. doi: 10.1073/pnas.2013102117. - DOI - PMC - PubMed
-
- Gaudreault N.N., Trujillo J.D., Carossino M., Meekins D.A., Morozov I., Madden D.W., Indran S.V., Bold D., Balaraman V., Kwon T., et al. SARS-CoV-2 infection, disease and transmission in domestic cats. Emerg. Microbes Infect. 2020;9:2322–2332. doi: 10.1080/22221751.2020.1833687. - DOI - PMC - PubMed
-
- Zhang Q., Zhang H., Huang K., Yang Y., Hui X., Gao J., He X., Li C., Gong W., Zhang Y., et al. SARS-CoV-2 Neutralizing Serum Antibodies in Cats: A Serological Investigation. [(accessed on 30 March 2021)];bioRxiv. 2020 Available online: https://www.biorxiv.org/content/10.1101/2020.04.01.021196v1. - DOI
-
- World Organisation for Animal Health OIE. [(accessed on 12 June 2021)]; Available online: https://www.oie.int/en/what-we-offer/emergency-and-resilience/covid-19/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
